Clinical trial

Post-exercise Insulin Reductions in Type 1 Diabetes

NCT01531855

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2012-02-01

PhaseNA

Study timeline

Study start (unknown)2012-02-01Date precision: month

Registry last updated2014-08-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Type 1 Diabetesverified · MONDO: type 1 diabetes mellitus

Interventions

Reducing post-exercise rapid-acting insulin (insulin lispro or aspart) doseOTHER

Sponsors & collaborators

Northumbria Universitylead sponsor

Diabetes UKcollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01531855 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.